Latest Equity Capital Markets News

Aeris Resources has reported a robust half-year performance with a 62% jump in profit, a successful $101.6 million equity raise, and a strategic divestment of North Queensland assets. The company also announced plans to acquire Peel Mining’s South Cobar Copper Project, signaling an aggressive growth trajectory.

Genesis Energy has completed a NZ$100 million share placement at NZ$2.15 per share, paving the way for a NZ$300 million rights offer to fund its renewable energy expansion under the Gen35 strategy.

Amaero Ltd has announced plans to re-domicile from Australia to the United States, aiming to tap into larger capital markets and position itself for a potential US IPO by late 2026 or early 2027. The move retains its ASX listing while opening doors to broader investor pools and strategic growth opportunities.

Advanced Innergy Holdings Ltd (ASX:AIH) has reported a robust FY25 performance highlighted by a successful IPO and strong growth across its core segments, setting a confident tone for FY26.

Bell Financial Group delivered a robust 17.1% rise in net profit after tax to $36 million for 2025, driven by strong growth in its Platforms division and a rebound in market activity. The company declared a fully franked final dividend of 6.5 cents per share, signalling confidence as it prepares to launch a new wealth management platform in 2026.

Contact Energy has successfully completed a NZ$450 million placement as part of a NZ$525 million equity raise, supported by both existing and new international investors. The company now opens a NZ$75 million retail offer to eligible shareholders, marking a significant capital expansion.

Resolution Minerals has taken a significant step towards expanding its footprint in the US capital markets by lodging a registration statement with the SEC and launching an ADR facility, while divesting a non-core Alaskan asset to focus on key US projects.

Cynata Therapeutics has successfully raised $1.2 million through an At-The-Market equity raise, issuing shares at a discount to support its ongoing clinical programs. This capital injection aims to bolster working capital as the company advances its proprietary stem cell therapies.

Euroz Hartleys reports a striking 121% jump in net profit for H1 FY2026, driven by booming equity capital markets activity and rising advisory fees. The company also lifts its interim dividend, signalling confidence amid cyclical market conditions.

American Tungsten & Antimony Ltd is progressing its Nasdaq listing plans with a confidential SEC filing expected in March 2026 and has appointed Deutsche Bank as ADR depositary alongside a new CFO to support growth.

Origin Energy backs a landmark US$1 billion equity raise for Kraken Technologies, valuing the company at US$8.65 billion and maintaining a significant stake as Kraken prepares to separate from Octopus Energy.

Cann Group Limited has successfully completed a significant debt restructure and equity raising, improving its financial footing and liquidity to support future growth.